Features
Combating Inappropriate Polypharmacy
Older adults are especially prone to inappropriate polypharmacy because they commonly have multiple medical problems and see a variety of specialists.
Two studies show lack of benefit in primary or secondary end points with cinpanemab or prasinezumab versus placebo
Most neurological disorders do not appear to be more frequent after COVID-19 than after influenza or bacterial pneumonia
Lower risk of parkinsonism partly mediated by reduced odds of brain atherosclerosis